Divalproex Sodium for Prevention of Migraine
Abstract
The use of divalproex sodium (DVS) as a prophylactic treatment for migraine was studied in 42 patients, 7 to 16 years of age (mean age, 11.3 years) seen between July 1996 and December 1998 at St Jude Children’s Research Hospital, Memphis, TN; and Hasbro Children’s Hospital/Rhode Island Hospital,Divalproex Brown University, Providence, RI.
DOI: https://doi.org/10.15844/pedneurbriefs-14-11-4 | Journal eISSN: 2166-6482
Language: English
Page range: 83 - 83
Published on: Nov 1, 2000
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 2000 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.